CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 1.96 HKD -1.51% Market Closed
Market Cap: 2.5B HKD
Have any thoughts about
CStone Pharmaceuticals?
Write Note

Wall Street
Price Targets

Price Targets Summary
CStone Pharmaceuticals

Wall Street analysts forecast CStone Pharmaceuticals stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 2.56 HKD with a low forecast of 2.54 HKD and a high forecast of 2.64 HKD.

Lowest
Price Target
2.54 HKD
29% Upside
Average
Price Target
2.56 HKD
31% Upside
Highest
Price Target
2.64 HKD
34% Upside
CStone Pharmaceuticals Competitors:
Price Targets
ELDN
Eledon Pharmaceuticals Inc
209% Upside
688363
Bloomage Biotechnology Corp Ltd
0% Upside
FLUO
Fluoguide AS
309% Upside
ANAB
AnaptysBio Inc
156% Upside
AUPH
Aurinia Pharmaceuticals Inc
24% Upside
GLPG
Galapagos NV
42% Upside
BCRX
BioCryst Pharmaceuticals Inc
96% Upside
BAVA
Bavarian Nordic A/S
60% Upside

Revenue
Forecast

Revenue Estimate
CStone Pharmaceuticals

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 26%.

N/A
Past Growth
26%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CStone Pharmaceuticals's stock price target?
Price Target
2.56 HKD

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 2.56 HKD with a low forecast of 2.54 HKD and a high forecast of 2.64 HKD.

What is CStone Pharmaceuticals's Revenue forecast?
Projected CAGR
26%

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 26%.

Back to Top